PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 10:15 AM ET

Sponsor Check › Person

PH
No photo found yet (own website and image search run after this page is viewed)

Peter Harwin

Named as an officer, director or promoter on SEC Form D filings · MA, PA, CO, TX · Oct 6, 2016 → Oct 8, 2026

20deals (issuers)
$2.55Breported sold
369investors
47Form D filings
2016–2026years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:16 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Peter Harwin is listed as an executive officer, director, and promoter on 47 SEC Form D filings by 20 issuers between Oct 2016 and Oct 2026. Largest by amount reported sold: Fairmount Healthcare Feeder Fund II L.P. (West Conshohocken, PA — pooled investment fund — 2019–2026; $1.07B reported sold to 51 investors), Fairmount Healthcare Fund II L.P. (West Conshohocken, PA — pooled investment fund — 2019–2026; $667M reported sold to 52 investors), Galecto, Inc. (Boston, MA — biotechnology — 2025; $285M reported sold to 48 investors), Spyre Therapeutics, Inc. (Waltham, MA — biotechnology — 2023; $210M reported sold to 54 investors), Unum Therapeutics Inc. (Cambridge, MA — biotechnology — 2020; $104.4M reported sold to 22 investors) and 15 more (all listed below).

What this means That is a lot of deals — 20 separate companies raised money with this person listed as executive officer, director, and promoter, over about 10 years. Across those companies the filings report $2.55B sold in total.

Listed alongside Tomas Kiselak (43 shared filings), Fairmount Funds Management LLC (21 shared filings, management entity), Fairmount Healthcare Fund II GP LLC (12 shared filings, management entity), Investment Manager Fairmount Funds Management LLC (10 shared filings, management entity), General Partner Fairmount Healthcare Fund GP LLC (5 shared filings, management entity) and 46 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Peter. Each name links to their own page.

The issuers belong to 2 sponsor groups: Fairmount Healthcare (15 issuers, $1.85B reported sold, 2016–2026) and Miragen Therapeutics (2 issuers, $131.7M reported sold, 2009–2020).

What this means This person is listed across more than one sponsor team; each group page shows that team's full track record.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY) — 4 court cases matching the name, 3 bankruptcy cases matching the name listed in Key records below.

What this means 7 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 47 public filings for Peter Harwin and found 19 differences, 4 worth asking the sponsor about: Bankruptcy case: United Harwin Group L.P; Investor count went down between filings; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Peter Harwin has not run yet — it is joining a line of 50,055 names; searches run around the clock at the hosts' allowed rate. Searched so far: 641 names.

Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

4 cases: 3 closed (disposition not in docket feed), 1 judgment

Garcia v. Shops@Harwin Complex, LLC closed
District Court, S.D. Texas · No. 4:25-cv-00943 · Filed Mar 3, 2025 · Closed Jun 11, 2025
Role of Shops@Harwin Complex, LLC: Defendant · Outcome: Terminated 2025-06-11 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same rare surname (1 person in Form D filings, 26 federal dockets); different first name (shops); court in the person's filing state (TX)
Sampson v. Harwin Properties, L.P. closed
District Court, S.D. Texas · No. 4:25-cv-00264 · Filed Jan 22, 2025 · Closed Mar 13, 2025
Role of Harwin Properties, L.P.: Defendant · Outcome: Terminated 2025-03-13 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same rare surname (1 person in Form D filings, 26 federal dockets); surname only in the caption; court in the person's filing state (TX)
Harwin International Plaza Owners Association v. Cuideone Specialty Insurance Company closed
District Court, S.D. Texas · No. 4:23-cv-01870 · Filed May 22, 2023 · Closed Nov 12, 2024
Role of Harwin International Plaza Owners Association: Plaintiff · Outcome: Terminated 2024-11-12 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same rare surname (1 person in Form D filings, 26 federal dockets); surname only in the caption; court in the person's filing state (TX)
Harwin Cell & Parts, LLC v. Federal Express Corporation judgment
District Court, S.D. Texas · No. 4:17-cv-01515 · Filed May 17, 2017 · Closed Oct 10, 2018 · Nature of suit: 190 Contract: Other · Cause: 28:1331 Fed. Question
Role of Harwin Cell & Parts, LLC: Plaintiff · Outcome: Terminated 2018-10-10 — FJC Integrated Database disposition: Judgment on motion before trial; judgment for defendant Docket on CourtListener ↗
same rare surname (1 person in Form D filings, 26 federal dockets); surname only in the caption; court in the person's filing state (TX)
What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:16 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: 48 regulators (FINRA, NASAA, 37 states) — crawled Oct 24, 2026, 8:48 AM ET

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Peter Harwin..

State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).

3. Bankruptcies

3 cases: 3 closed (disposition not in docket feed)

AZA Investments, LLC v. 7636 Harwin, LLC closed
United States Bankruptcy Court, N.D. Texas · No. 14-03079 · Filed Jun 2, 2014 · Closed Dec 4, 2014
Role of 7636 Harwin, LLC: Defendant · Outcome: Case closed 2014-12-04 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same rare surname (1 person in Form D filings, 26 federal dockets); different first name (llc); court in the person's filing state (TX)
United Harwin Group L.P. closed
United States Bankruptcy Court, S.D. Texas · No. 10-38009 · Filed Sep 7, 2010 · Closed Jan 13, 2011
Role of United Harwin Group L.P.: Debtor · Outcome: Case closed 2011-01-13 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same rare surname (1 person in Form D filings, 26 federal dockets); surname only in the caption; court in the person's filing state (TX)
Grochocinski v. Harwin Inc. closed
United States Bankruptcy Court, N.D. Illinois · No. 06-00773 · Filed Mar 16, 2006 · Closed May 8, 2006
Role of Harwin Inc.: Defendant · Outcome: Case closed 2006-05-08 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same rare surname (1 person in Form D filings, 26 federal dockets); surname only in the caption; court in IL (not a filing state)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:16 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

19 differences found between the filings for Peter Harwin — 4 worth asking about (compared 47 filings on Oct 24, 2026)

Worth asking · Sep 7, 2010 – Jan 13, 2011

Bankruptcy case: United Harwin Group L.P. — filed Sep 7, 2010

United States Bankruptcy Court, S.D. Texas docket "United Harwin Group L.P." filed Sep 7, 2010, closed Jan 13, 2011. Peter Harwin is listed as Debtor ("United Harwin Group L.P."). Our match estimate: 53%.

What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.

Docket · United States Bankruptcy Court, S.D. Texas ↗
Sources
Note · May 17, 2017 – Jan 22, 2025

3 court cases name Peter Harwin — 1 as defendant

By role: defendant in 1, plaintiff in 2. Newest: "Sampson v. Harwin Properties, L.P." (District Court, S.D. Texas, Jan 22, 2025); "Harwin International Plaza Owners Association v. Cuideone Specialty Insurance Company" (District Court, S.D. Texas, May 22, 2023); "Harwin Cell & Parts, LLC v. Federal Express Corporation" (District Court, S.D. Texas, May 17, 2017). Some of these are name matches with a match estimate below 95% — check each docket.

What this means Several court cases name this subject. Some are routine business suits. Ask what each was about and how it ended.

Docket · Sampson v. Harwin Properties, L.P. ↗Docket · Harwin International Plaza Owners Association v. Cuideone Specialty Insurance Company ↗Docket · Harwin Cell & Parts, LLC v. Federal Express Corporation ↗
Sources
Worth asking · Nov 14, 2018 – Nov 7, 2019

Investor count went down between filings — Fairmount Healthcare Fund L.P.

The Nov 14, 2018 filing reports 65 investors; the Nov 7, 2019 Form D/A reports 43 investors.

What this means Investor counts normally only grow. A smaller number can mean investors left or were refunded, or a count was corrected. Ask the sponsor what happened.

Form D/A (earlier) · Nov 14, 2018 ↗Form D/A (later) · Nov 7, 2019 ↗Fairmount Healthcare Fund L.P. — PartnerFacts page ↗
Sources
Worth asking · Nov 14, 2018 – Nov 7, 2019

Investor count went down between filings — Fairmount Healthcare Feeder Fund Ltd.

The Nov 14, 2018 filing reports 8 investors; the Nov 7, 2019 Form D/A reports 6 investors.

What this means Investor counts normally only grow. A smaller number can mean investors left or were refunded, or a count was corrected. Ask the sponsor what happened.

Form D/A (earlier) · Nov 14, 2018 ↗Form D/A (later) · Nov 7, 2019 ↗Fairmount Healthcare Feeder Fund Ltd. — PartnerFacts page ↗
Sources
Note · Dec 13, 2018

Peter Harwin appears on 1 deal that stopped filing before reaching its target

Viridian, LLC (last filing Dec 13, 2018; $1,150,000 sold of $3,000,000). Each has no filing in more than two years and reported under half its target sold.

What this means An issuer whose last filing is more than two years old and reported under half its target sold. The raise may have closed early or quietly stopped. Ask what happened to each.

Viridian, LLC — PartnerFacts page ↗
Sources
Note · Dec 11, 2023 – Dec 27, 2023

Form D filed 16 days after the first sale — Spyre Therapeutics, Inc.

The filing says the first sale was Dec 11, 2023. The Form D was filed Dec 27, 2023 — 16 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 1 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Form D · Dec 27, 2023 ↗Spyre Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Jul 10, 2023 – Aug 21, 2023

Form D filed 42 days after the first sale — Fairmount Healthcare Co-Invest II L.P.

The filing says the first sale was Jul 10, 2023. The Form D was filed Aug 21, 2023 — 42 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 27 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Form D · Aug 21, 2023 ↗Fairmount Healthcare Co-Invest II L.P. — PartnerFacts page ↗
Sources
Note · Jan 30, 2019 – Mar 5, 2019

Form D filed 34 days after the first sale — Fairmount Healthcare Feeder Fund II L.P.

The filing says the first sale was Jan 30, 2019. The Form D was filed Mar 5, 2019 — 34 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 19 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Form D · Mar 5, 2019 ↗Fairmount Healthcare Feeder Fund II L.P. — PartnerFacts page ↗
Sources
Note · Oct 14, 2016 – Oct 27, 2020

5 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — Fairmount Healthcare Fund L.P. (latest filing Oct 27, 2020) · No amendment in the last 12 months on an offering that may still be open — Fairmount Healthcare Feeder Fund Ltd. (latest filing Oct 27, 2020) · No amendment in the last 12 months on an offering that may still be open — Viridian Therapeutics, Inc. (latest filing May 8, 2020) · No amendment in the last 12 months on an offering that may still be open — Viridian, LLC (latest filing Dec 13, 2018) · No amendment in the last 12 months on an offering that may still be open — Quellis Biosciences, Inc. (latest filing Jun 1, 2018)

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D/A · Oct 27, 2020 ↗Fairmount Healthcare Fund L.P. — PartnerFacts page ↗Form D/A · Oct 27, 2020 ↗Fairmount Healthcare Feeder Fund Ltd. — PartnerFacts page ↗
Sources
Worth asking · Dec 11, 2018 – Aug 18, 2020

Peter Harwin is no longer listed on the Aug 18, 2020 amendment — Quellis Biosciences, Inc.

Peter Harwin appears on the Dec 11, 2018 Form D (executive officer, director) but not on the Aug 18, 2020 Form D/A for the same offering.

What this means People leave, and the issuer must list only current officers, directors and promoters. It is still worth asking why this person left and who replaced them.

Form D · Dec 11, 2018 ↗Form D/A · Aug 18, 2020 ↗Peter Harwin — PartnerFacts page ↗Quellis Biosciences, Inc. — PartnerFacts page ↗
Sources
Note · May 5, 2023 – Sep 18, 2023

Peter Harwin's role changed at Fairmount Healthcare Feeder Fund II L.P.: executive officer, director, promoter → executive officer, promoter

The May 5, 2023 filing lists Peter Harwin as executive officer, director, promoter; the Sep 18, 2023 Form D/A lists executive officer, promoter.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D/A · May 5, 2023 ↗Form D/A · Sep 18, 2023 ↗Peter Harwin — PartnerFacts page ↗Fairmount Healthcare Feeder Fund II L.P. — PartnerFacts page ↗
Sources
Note · Feb 28, 2020 – May 19, 2021

Peter Harwin's role changed at Fairmount Healthcare Feeder Fund II L.P.: executive officer, promoter → executive officer, director, promoter

The Feb 28, 2020 filing lists Peter Harwin as executive officer, promoter; the May 19, 2021 Form D/A lists executive officer, director, promoter.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D/A · Feb 28, 2020 ↗Form D/A · May 19, 2021 ↗Peter Harwin — PartnerFacts page ↗Fairmount Healthcare Feeder Fund II L.P. — PartnerFacts page ↗
Sources
Note · Dec 11, 2018 – Aug 18, 2020

Offering amount changed between filings — Quellis Biosciences, Inc.

The Dec 11, 2018 filing says $18,518,047 offered; the Aug 18, 2020 Form D/A says $18,519,814.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Form D (earlier) · Dec 11, 2018 ↗Form D/A (later) · Aug 18, 2020 ↗Quellis Biosciences, Inc. — PartnerFacts page ↗
Sources
Note · May 5, 2023 – Jun 3, 2024

Minimum investment changed between filings — Fairmount Healthcare Fund II L.P.

The May 5, 2023 filing lists a minimum of $1,000,000; the Jun 3, 2024 Form D/A lists $1.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D/A (earlier) · May 5, 2023 ↗Form D/A (later) · Jun 3, 2024 ↗Fairmount Healthcare Fund II L.P. — PartnerFacts page ↗
Sources
Note · May 5, 2023 – Sep 18, 2023

Minimum investment changed between filings — Fairmount Healthcare Feeder Fund II L.P.

The May 5, 2023 filing lists a minimum of $1,000,000; the Sep 18, 2023 Form D/A lists $1.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D/A (earlier) · May 5, 2023 ↗Form D/A (later) · Sep 18, 2023 ↗Fairmount Healthcare Feeder Fund II L.P. — PartnerFacts page ↗
Sources
Note · Oct 6, 2016 – Nov 6, 2020

Peter Harwin is written 2 different ways on the filings

listed as "Peter Harwin" on 46 filings (from Oct 6, 2016), and "Peter E. Harwin" on the Nov 6, 2020 filing.

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D · Oct 6, 2016 ↗Form D · Nov 6, 2020 ↗Peter Harwin — PartnerFacts page ↗
Sources
Note · Mar 5, 2019

Formed in 2023 per the latest filing, but activity is dated 2019 — Fairmount Healthcare Feeder Fund II L.P.

The issuer's latest filing says it was formed in 2023. The Mar 5, 2019 filing says the first sale was Jan 30, 2019 — before that year.

What this means A company cannot sell before it exists, so one of the two dates is likely a typo on the form. Ask the sponsor for the formation document.

Form D · Mar 5, 2019 ↗Fairmount Healthcare Feeder Fund II L.P. — PartnerFacts page ↗
Sources
Note · Dec 11, 2018 – Dec 27, 2023

4 address changes between filings

Address moved from Austin, TX to Waltham, MA — Spyre Therapeutics, Inc. · Address moved from Philadelphia, PA to West Conshohocken, PA — Fairmount Healthcare Feeder Fund II L.P. · Address moved from Philadelphia, PA to West Conshohocken, PA — Fairmount Healthcare Fund II L.P. · Address moved from Philadelphia, PA to Waltham, MA — Quellis Biosciences, Inc.

What this means Businesses move. If you were told one city and the forms say another, ask which is current.

Form D · Jul 6, 2023 ↗Form D · Dec 27, 2023 ↗Spyre Therapeutics, Inc. — PartnerFacts page ↗Form D/A · May 19, 2022 ↗
Sources
Note · Oct 6, 2016 – Oct 8, 2026

Peter Harwin is listed with 4 different address states: PA, MA, CO, TX

PA on 39 filings (Oct 6, 2016 to Oct 8, 2026); MA on 6 filings (May 8, 2020 to Nov 21, 2025); CO on 1 filing (Nov 6, 2020); TX on 1 filing (Jul 6, 2023).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Form D · Oct 6, 2016 ↗Form D · May 8, 2020 ↗Form D · Nov 6, 2020 ↗Form D · Jul 6, 2023 ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

0 of 24 offerings report sales commissions; 4 report finder's fees totalling $45,049,881; 0 report proceeds to related persons.

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Oct 8, 2026 D
Fairmount Healthcare Co-Invest VII L.P.
File 021-600543
$0$0$0None listed on this filingEDGAR ↗
May 29, 2026 D/A
Fairmount Healthcare Feeder Fund II L.P.
File 021-334107
$0$0$0None listed on this filingEDGAR ↗
May 29, 2026 D/A
Fairmount Healthcare Fund II L.P.
File 021-334111
$0$0$0None listed on this filingEDGAR ↗
Apr 3, 2026 D
Paragon Laboratories L.P.
File 021-579089
$0$0$0None listed on this filingEDGAR ↗
Mar 31, 2026 D
Fairmount Healthcare Co-Invest VI L.P.
File 021-578593
$0$0$0None listed on this filingEDGAR ↗
Nov 21, 2025 D
Galecto, Inc.
File 021-564756
$0$17,100,000$0Jefferies LLC BrokerCheck CRD 2347 ↗
Leerink Partners LLC BrokerCheck CRD 39011 ↗
UBS Securities LLC BrokerCheck CRD 7654 ↗
LifeSci Capital, LLC BrokerCheck CRD 168404 ↗		EDGAR ↗
Nov 5, 2025 D
Fairmount Healthcare Co-Invest V L.P.
File 021-563202
$0$0$0None listed on this filingEDGAR ↗
Oct 31, 2024 D
Fairmount Healthcare Co-Invest IV L.P.
File 021-528380
$0$0$0None listed on this filingEDGAR ↗
Mar 29, 2024 D
Fairmount Healthcare Co-Invest III L.P.
File 021-509054
$0$0$0None listed on this filingEDGAR ↗
Dec 27, 2023 D
Spyre Therapeutics, Inc.
File 021-500772
$0$10,800,000$0Jefferies LLC BrokerCheck CRD 2347 ↗
Cowen and Company, LLC BrokerCheck CRD 7616 ↗
Stifel, Nicolaus & Company, Incorporated BrokerCheck CRD 793 ↗
Guggenheim Securities, LLC BrokerCheck CRD 40638 ↗
LifeSci Capital LLC BrokerCheck CRD 168404 ↗		EDGAR ↗
Aug 21, 2023 D
Fairmount Healthcare Co-Invest II L.P.
File 021-490287
$0$0$0None listed on this filingEDGAR ↗
Jul 6, 2023 D
Spyre Therapeutics, Inc.
File 021-486102
$0$12,600,015$0Jefferies LLC BrokerCheck CRD 2347 ↗
Cowen and Company, LLC BrokerCheck CRD 7616 ↗
Stifel, Nicolaus & Company, Incorporated BrokerCheck CRD 793 ↗
Guggenheim Securities, LLC BrokerCheck CRD 40638 ↗		EDGAR ↗
Jun 30, 2023 D
Fairmount Healthcare Co-Invest L.P.
File 021-485732
$0$0$0None listed on this filingEDGAR ↗
May 10, 2021 D
Paragon Therapeutics, Inc.
File 021-398700
$0$0$0None listed on this filingEDGAR ↗
Nov 6, 2020 D
MIRAGEN THERAPEUTICS, INC.
File 021-379997
$0$4,549,866$0Jefferies LLC BrokerCheck CRD 2347 ↗
JMP Securities LLC BrokerCheck CRD 22208 ↗		EDGAR ↗
Oct 27, 2020 D/A
Fairmount Healthcare Feeder Fund Ltd.
File 021-271986
$0$0$0None listed on this filingEDGAR ↗
Oct 27, 2020 D/A
Fairmount Healthcare Fund L.P.
File 021-271988
$0$0$0None listed on this filingEDGAR ↗
Sep 29, 2020 D
Viridian Therapeutics, Inc.
File 021-376545
$0$0$0None listed on this filingEDGAR ↗
Jul 21, 2020 D
Unum Therapeutics Inc.
File 021-371480
$0$0$0None listed on this filingEDGAR ↗
Jul 21, 2020 D
Unum Therapeutics Inc.
File 021-371481
$0$0$0None listed on this filingEDGAR ↗
May 8, 2020 D
Viridian Therapeutics, Inc.
File 021-366547
$0$0$0None listed on this filingEDGAR ↗
Dec 13, 2018 D
Viridian, LLC
File 021-327913
$0$0$0None listed on this filingEDGAR ↗
Dec 11, 2018 D
Quellis Biosciences, Inc.
File 021-327586
$0$0$0None listed on this filingEDGAR ↗
Jun 1, 2018 D
Quellis Biosciences, Inc.
File 021-313711
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 20

Every issuer that named Peter Harwin on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

FH
Pooled Investment Fund · group: Fairmount Healthcare

Fairmount Healthcare Co-Invest VII L.P.

West Conshohocken, PA · Oct 8, 2026
  • Oct 8, 2026 · D · $0 sold of Indefinite · 0 investors · min. $1 · role: Executive Officer, Promoter (Managing Member of the Member of the General Partner and Investment Manager of the Issuer) EDGAR ↗

No sales reported yet as of the latest filing. Peter is listed as executive officer, promoter.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

FH
Pooled Investment Fund · group: Fairmount Healthcare

Fairmount Healthcare Feeder Fund II L.P.

West Conshohocken, PA · Mar 5, 2019 → May 29, 2026 · 9 filings
  • May 29, 2026 · D/A · $1,074,275,867 sold of Indefinite · 51 investors · min. $1 · role: Executive Officer, Promoter (Managing Member of the General Partner and Investment Manager) EDGAR ↗
  • May 29, 2025 · D/A · $944,859,587 sold of Indefinite · 36 investors · min. $1 · role: Executive Officer, Promoter (Managing Member of the General Partner and Investment Manager) EDGAR ↗
  • Jun 3, 2024 · D/A · $673,309,587 sold of Indefinite · 23 investors · min. $1 · role: Executive Officer, Promoter (Managing Member of the General Partner and Investment Manager) EDGAR ↗
  • Sep 18, 2023 · D/A · $517,390,000 sold of Indefinite · 20 investors · min. $1 · role: Executive Officer, Promoter (Managing Member of the General Partner and Investment Manager) EDGAR ↗
  • May 5, 2023 · D/A · $377,390,000 sold of Indefinite · 19 investors · min. $1,000,000 · role: Executive Officer, Director, Promoter (Managing Member of Investment Manager and Director of the Issuer) EDGAR ↗
  • May 19, 2022 · D/A · $345,640,000 sold of Indefinite · 18 investors · min. $1,000,000 · role: Executive Officer, Director, Promoter (Managing Member of Investment Manager and Director of the Issuer) EDGAR ↗
  • May 19, 2021 · D/A · $233,350,000 sold of Indefinite · 15 investors · min. $1,000,000 · role: Executive Officer, Director, Promoter (Managing Member of Investment Manager and Director of the Issuer) EDGAR ↗
  • Feb 28, 2020 · D/A · $105,000,000 sold of Indefinite · 3 investors · min. $1,000,000 · role: Executive Officer, Promoter EDGAR ↗
  • Mar 5, 2019 · D · $5,000,000 sold of Indefinite · 1 investors · min. $1,000,000 · role: Executive Officer, Promoter EDGAR ↗

Raised $1.07B from 51 investors as of the latest filing. Peter is listed as executive officer, promoter, director on 9 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

FH
Pooled Investment Fund · group: Fairmount Healthcare

Fairmount Healthcare Fund II L.P.

West Conshohocken, PA · Mar 5, 2019 → May 29, 2026 · 8 filings
  • May 29, 2026 · D/A · $667,035,598 sold of Indefinite · 52 investors · min. $1 · role: Executive Officer, Promoter (Managing Member of the General Partner and Investment Manager) EDGAR ↗
  • May 29, 2025 · D/A · $598,310,426 sold of Indefinite · 45 investors · min. $1 · role: Executive Officer, Promoter (Managing Member of the General Partner and Investment Manager) EDGAR ↗
  • Jun 3, 2024 · D/A · $524,160,426 sold of Indefinite · 40 investors · min. $1 · role: Executive Officer, Promoter (Managing Member of the General Partner and Investment Manager) EDGAR ↗
  • May 5, 2023 · D/A · $461,571,653 sold of Indefinite · 26 investors · min. $1,000,000 · role: Executive Officer, Promoter (Managing Member of the General Partner and Investment Manager) EDGAR ↗
  • May 19, 2022 · D/A · $449,571,653 sold of Indefinite · 22 investors · min. $1,000,000 · role: Executive Officer, Promoter (Managing Member of the General Partner and Investment Manager) EDGAR ↗
  • May 19, 2021 · D/A · $288,971,653 sold of Indefinite · 20 investors · min. $1,000,000 · role: Executive Officer, Promoter (Managing Member of the General Partner and Investment Manager) EDGAR ↗
  • Feb 28, 2020 · D/A · $53,571,653 sold of Indefinite · 8 investors · min. $1,000,000 · role: Executive Officer, Promoter (Managing Member of the General Partner and Promoter of the Issuer) EDGAR ↗
  • Mar 5, 2019 · D · $2,500,000 sold of Indefinite · 1 investors · min. $1,000,000 · role: Executive Officer, Promoter (Managing Member of the General Partner and Promoter of the Issuer) EDGAR ↗

Raised $667M from 52 investors as of the latest filing. Peter is listed as executive officer, promoter on 8 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

PL
Pooled Investment Fund · group: Fairmount Healthcare

Paragon Laboratories L.P.

West Conshohocken, PA · Apr 3, 2026
  • Apr 3, 2026 · D · $0 sold of Indefinite · 0 investors · min. $1 · role: Executive Officer, Promoter (Managing Member of the General Partner and Investment Manager of the Issuer) EDGAR ↗

No sales reported yet as of the latest filing. Peter is listed as executive officer, promoter.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

FH
Pooled Investment Fund · group: Fairmount Healthcare

Fairmount Healthcare Co-Invest VI L.P.

West Conshohocken, PA · Mar 31, 2026
  • Mar 31, 2026 · D · $0 sold of Indefinite · 0 investors · min. $1 · role: Executive Officer, Promoter (Managing Member of the Member of the General Partner and Investment Manager of the Issuer) EDGAR ↗

No sales reported yet as of the latest filing. Peter is listed as executive officer, promoter.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

G
Biotechnology

Galecto, Inc.

Boston, MA · Nov 21, 2025
  • Nov 21, 2025 · D · $285,000,000 sold of $285,000,000 · 48 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $285M from 48 investors (100% of the $285M target) as of the latest filing. Peter is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

FH
Pooled Investment Fund · group: Fairmount Healthcare

Fairmount Healthcare Co-Invest V L.P.

West Conshohocken, PA · Nov 5, 2025
  • Nov 5, 2025 · D · $0 sold of Indefinite · 0 investors · min. $1 · role: Executive Officer, Promoter (Managing Member of the Member of the General Partner and Investment Manager of the Issuer) EDGAR ↗

No sales reported yet as of the latest filing. Peter is listed as executive officer, promoter.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

FH
Pooled Investment Fund · group: Fairmount Healthcare

Fairmount Healthcare Co-Invest IV L.P.

West Conshohocken, PA · Oct 31, 2024
  • Oct 31, 2024 · D · $0 sold of Indefinite · 0 investors · min. $1 · role: Executive Officer, Promoter (Managing Member of the Member of the General Partner and Investment Manager of the Issuer) EDGAR ↗

No sales reported yet as of the latest filing. Peter is listed as executive officer, promoter.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

FH
Pooled Investment Fund · group: Fairmount Healthcare

Fairmount Healthcare Co-Invest III L.P.

West Conshohocken, PA · Mar 29, 2024
  • Mar 29, 2024 · D · $0 sold of Indefinite · 0 investors · min. $1 · role: Executive Officer, Promoter (Managing Member of the General Partner and Investment Manager of the Issuer) EDGAR ↗

No sales reported yet as of the latest filing. Peter is listed as executive officer, promoter.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

ST
Biotechnology

Spyre Therapeutics, Inc.

Waltham, MA · Jul 6, 2023 → Dec 27, 2023 · 2 filings
  • Dec 27, 2023 · D · $180,000,000 sold of $180,000,000 · 30 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 6, 2023 · D · $210,000,248 sold of $210,000,248 · 41 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $210M from 54 investors (100% of the $180M target) as of the latest filing. Peter is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

FH
Pooled Investment Fund · group: Fairmount Healthcare

Fairmount Healthcare Co-Invest II L.P.

West Conshohocken, PA · Aug 21, 2023
  • Aug 21, 2023 · D · $15,173,000 sold of $15,173,000 · 14 investors · min. $1 · role: Executive Officer, Promoter (Managing Member of the General Partner and Investment Manager of the Issuer) EDGAR ↗

Raised $15.2M from 14 investors (100% of the $15.2M target) as of the latest filing. Peter is listed as executive officer, promoter.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

FH
Pooled Investment Fund · group: Fairmount Healthcare

Fairmount Healthcare Co-Invest L.P.

West Conshohocken, PA · Jun 30, 2023
  • Jun 30, 2023 · D · $25,000,000 sold of $25,000,000 · 18 investors · min. $1 · role: Executive Officer, Promoter (Managing Member of the General Partner and Investment Manager) EDGAR ↗

Raised $25M from 18 investors (100% of the $25M target) as of the latest filing. Peter is listed as executive officer, promoter.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

PT
Biotechnology · group: Fairmount Healthcare

Paragon Therapeutics, Inc.

Philadelphia, PA · May 10, 2021
  • May 10, 2021 · D · $10,000,000 sold of $10,000,000 · 2 investors · min. No minimum reported · role: Director, Promoter EDGAR ↗

Raised $10M from 2 investors (100% of the $10M target) as of the latest filing. Peter is listed as director, promoter.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

MT
Biotechnology · group: Miragen Therapeutics

MIRAGEN THERAPEUTICS, INC.

Boulder, CO · Nov 6, 2020
  • Nov 6, 2020 · D · $90,997,328 sold of $90,997,328 · 22 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $91M from 22 investors (100% of the $91M target) as of the latest filing. Peter is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

FH
Pooled Investment Fund · group: Fairmount Healthcare

Fairmount Healthcare Fund L.P.

Philadelphia, PA · Oct 6, 2016 → Oct 27, 2020 · 5 filings
  • Oct 27, 2020 · D/A · $27,961,532 sold of Indefinite · 43 investors · min. $1,000,000 · role: Executive Officer, Promoter (Manager of the General Partner) EDGAR ↗
  • Nov 7, 2019 · D/A · $27,156,532 sold of Indefinite · 43 investors · min. $1,000,000 · role: Executive Officer, Promoter (Manager of the General Partner) EDGAR ↗
  • Nov 14, 2018 · D/A · $23,578,998 sold of Indefinite · 65 investors · min. $1,000,000 · role: Executive Officer, Promoter (Manager of the General Partner) EDGAR ↗
  • Oct 6, 2017 · D/A · $13,442,430 sold of Indefinite · 27 investors · min. $1,000,000 · role: Executive Officer, Promoter (Manager of the General Partner) EDGAR ↗
  • Oct 6, 2016 · D · $0 sold of Indefinite · 0 investors · min. $1,000,000 · role: Executive Officer, Promoter (Manager of the General Partner) EDGAR ↗

Raised $28M from 65 investors as of the latest filing. Peter is listed as executive officer, promoter on 5 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

FH
Pooled Investment Fund · group: Fairmount Healthcare

Fairmount Healthcare Feeder Fund Ltd.

Philadelphia, PA · Oct 6, 2016 → Oct 27, 2020 · 5 filings
  • Oct 27, 2020 · D/A · $3,634,510 sold of Indefinite · 6 investors · min. $1,000,000 · role: Executive Officer, Promoter EDGAR ↗
  • Nov 7, 2019 · D/A · $3,628,549 sold of Indefinite · 6 investors · min. $1,000,000 · role: Executive Officer, Promoter EDGAR ↗
  • Nov 14, 2018 · D/A · $3,573,549 sold of Indefinite · 8 investors · min. $1,000,000 · role: Executive Officer, Promoter EDGAR ↗
  • Oct 6, 2017 · D/A · $1,543,933 sold of Indefinite · 4 investors · min. $1,000,000 · role: Executive Officer, Promoter EDGAR ↗
  • Oct 6, 2016 · D · $0 sold of Indefinite · 0 investors · min. $1,000,000 · role: Executive Officer, Promoter EDGAR ↗

Raised $3.63M from 8 investors as of the latest filing. Peter is listed as executive officer, promoter on 5 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

VT
Biotechnology · group: Fairmount Healthcare

Viridian Therapeutics, Inc.

Waltham, MA · May 8, 2020 → Sep 29, 2020 · 2 filings
  • Sep 29, 2020 · D · $27,000,000 sold of $27,000,000 · 9 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 8, 2020 · D · $2,000,000 sold of $5,000,000 · 2 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $27M from 9 investors (100% of the $27M target) as of the latest filing. Peter is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

UT
Biotechnology

Unum Therapeutics Inc.

Cambridge, MA · Jul 21, 2020 → Jul 21, 2020 · 2 filings
  • Jul 21, 2020 · D · $104,400,000 sold of $104,400,000 · 22 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 21, 2020 · D · $44,812,154 sold of $44,812,154 · 2 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $104.4M from 22 investors (100% of the $104.4M target) as of the latest filing. Peter is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

V
Biotechnology · group: Fairmount Healthcare

Viridian, LLC

Philadelphia, PA · Dec 13, 2018
  • Dec 13, 2018 · D · $1,150,000 sold of $3,000,000 · 1 investors · min. No minimum reported · role: Executive Officer (Manager) EDGAR ↗

Raised $1.15M from 1 investor (38% of the $3M target) as of the latest filing. Peter is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

QB
Biotechnology

Quellis Biosciences, Inc.

Waltham, MA · Jun 1, 2018 → Dec 11, 2018 · 2 filings
  • Dec 11, 2018 · D · $2,500,000 sold of $18,518,047 · 1 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Jun 1, 2018 · D · $0 sold of Indefinite · 1 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $12.1M from 3 investors (65% of the $18.5M target) as of the latest filing. Peter is listed as executive officer, director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

People around Peter 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

FF
Management entity

Fairmount Funds Management LLC

Executive Officer · 21 shared filings (10 issuers)

Fairmount Funds Management LLC is on 10 issuers in total — a repeat sponsor. Their page lists every one.

FH
Management entity

Fairmount Healthcare Fund II GP LLC

Executive Officer, Promoter · 12 shared filings (2 issuers)

Listed on the same filings as Peter Harwin. Their page shows their other deals.

PL
Management entity

Paragon Labs GP LLC

Executive Officer, Promoter · 1 shared filing (1 issuer)

Listed on the same filings as Peter Harwin. Their page shows their other deals.

TK
No photo found yet (own website and image search run after this page is viewed)
Person

Tomas Kiselak

Executive Officer, Promoter, Director · 43 shared filings (17 issuers) · also on 3 other issuers

Tomas Kiselak is on 20 issuers in total — a repeat sponsor. Their page lists every one.

JV
No photo found yet (own website and image search run after this page is viewed)
Person

Jonathan Violin

Executive Officer, Director · 4 shared filings (3 issuers) · also on 3 other issuers

Jonathan Violin is on 6 issuers in total — a repeat sponsor. Their page lists every one.

AM
No photo found yet (own website and image search run after this page is viewed)
Person

Arlene Morris

Director · 3 shared filings (2 issuers) · also on 3 other issuers

Arlene Morris is on 5 issuers in total — a repeat sponsor. Their page lists every one.

AL
No photo found yet (own website and image search run after this page is viewed)
Person

Alison Lawton

Director · 2 shared filings (1 issuer) · also on 4 other issuers

Alison Lawton is on 5 issuers in total — a repeat sponsor. Their page lists every one.

JG
No photo found yet (own website and image search run after this page is viewed)
Person

John L. Green

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Peter Harwin. Their page shows their other deals.

CW
No photo found yet (own website and image search run after this page is viewed)
Person

Charles Wilson

Executive Officer, Director · 2 shared filings (1 issuer)

Listed on the same filings as Peter Harwin. Their page shows their other deals.

MR
No photo found yet (own website and image search run after this page is viewed)
Person

Matthew Ros

Director · 2 shared filings (1 issuer)

Listed on the same filings as Peter Harwin. Their page shows their other deals.

JS
No photo found yet (own website and image search run after this page is viewed)
Person

Jessica Sachs

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Peter Harwin. Their page shows their other deals.

CC
No photo found yet (own website and image search run after this page is viewed)
Person

Chris Cain

Director · 2 shared filings (1 issuer)

Listed on the same filings as Peter Harwin. Their page shows their other deals.

KF
No photo found yet (own website and image search run after this page is viewed)
Person

Karen Ferrante

Director · 2 shared filings (1 issuer)

Listed on the same filings as Peter Harwin. Their page shows their other deals.

MH
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Henderson

Director · 2 shared filings (1 issuer)

Listed on the same filings as Peter Harwin. Their page shows their other deals.

CT
No photo found yet (own website and image search run after this page is viewed)
Person

Cameron Turtle

Executive Officer, Director · 2 shared filings (1 issuer)

Listed on the same filings as Peter Harwin. Their page shows their other deals.

RC
No photo found yet (own website and image search run after this page is viewed)
Person

Russell J. Cox

Director · 2 shared filings (1 issuer)

Listed on the same filings as Peter Harwin. Their page shows their other deals.

CC
No photo found yet (own website and image search run after this page is viewed)
Person

Christopher Cain

Director · 1 shared filing (1 issuer)

Listed on the same filings as Peter Harwin. Their page shows their other deals.

GW
No photo found yet (own website and image search run after this page is viewed)
Person

Garrett Winslow

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Peter Harwin. Their page shows their other deals.

CG
No photo found yet (own website and image search run after this page is viewed)
Person

Carl Goldfischer

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Peter Harwin. Their page shows their other deals.

LF
No photo found yet (own website and image search run after this page is viewed)
Person

Lori Firmani

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Peter Harwin. Their page shows their other deals.

AM
No photo found yet (own website and image search run after this page is viewed)
Person

Amit Munshi

Director · 1 shared filing (1 issuer) · also on 4 other issuers

Amit Munshi is on 5 issuers in total — a repeat sponsor. Their page lists every one.

JD
No photo found yet (own website and image search run after this page is viewed)
Person

Jayson Dallas

Director · 1 shared filing (1 issuer)

Listed on the same filings as Peter Harwin. Their page shows their other deals.

JB
No photo found yet (own website and image search run after this page is viewed)
Person

Julianne Bruno

Director · 1 shared filing (1 issuer)

Listed on the same filings as Peter Harwin. Their page shows their other deals.

LR
No photo found yet (own website and image search run after this page is viewed)
Person

Lee Rauch

Executive Officer, Director · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Peter Harwin. Their page shows their other deals.

JA
No photo found yet (own website and image search run after this page is viewed)
Person

Jeffrey Albers

Director · 1 shared filing (1 issuer) · also on 4 other issuers

Jeffrey Albers is on 5 issuers in total — a repeat sponsor. Their page lists every one.

JH
No photo found yet (own website and image search run after this page is viewed)
Person

Jeffrey S. Hatfield

Director · 1 shared filing (1 issuer)

Listed on the same filings as Peter Harwin. Their page shows their other deals.

CG
No photo found yet (own website and image search run after this page is viewed)
Person

Chris Garabedian

Director · 1 shared filing (1 issuer) · also on 11 other issuers

Chris Garabedian is on 12 issuers in total — a repeat sponsor. Their page lists every one.

FC
No photo found yet (own website and image search run after this page is viewed)
Person

Fred Callori

Director · 1 shared filing (1 issuer) · also on 4 other issuers

Fred Callori is on 5 issuers in total — a repeat sponsor. Their page lists every one.

CG
No photo found yet (own website and image search run after this page is viewed)
Person

Christopher Garabedian

Director · 1 shared filing (1 issuer)

Listed on the same filings as Peter Harwin. Their page shows their other deals.

HS
No photo found yet (own website and image search run after this page is viewed)
Person

Hans Schambye

Executive Officer, Director · 1 shared filing (1 issuer)

Listed on the same filings as Peter Harwin. Their page shows their other deals.

FC
No photo found yet (own website and image search run after this page is viewed)
Person

Frederick Callori

Director · 1 shared filing (1 issuer) · also on 4 other issuers

Frederick Callori is on 5 issuers in total — a repeat sponsor. Their page lists every one.

The team behind the deals

FH
Sponsor group

Fairmount Healthcare

15 issuers · 39 filings · $1.85B reported sold · 2016–2026

One team, 15 deal companies. Peter Harwin is listed on 15 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Peter Harwin.

MT
Sponsor group

Miragen Therapeutics

2 issuers · 13 filings · $131.7M reported sold · 2009–2020

One team, 2 deal companies. Peter Harwin is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Peter Harwin.

Same business address

51 other issuers file from the same address (first 50 shown)

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Business registration (state registry / Secretary of State)

Individuals are not matched to business registrations — registries list companies, and a name alone is not enough to tie a person to one. Officers and managers appear by name inside each matched company's record on the issuer pages. Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file).

Adviser registration (Form ADV)

A person is never an adviser firm. 10 of the 20 issuers this person is listed on match a Form ADV adviser (searched 24,962 advisers as of Oct 2, 2026): Fairmount Healthcare Co-Invest VII L.P., Fairmount Healthcare Fund II L.P., Fairmount Healthcare Feeder Fund II L.P., Paragon Laboratories L.P., Fairmount Healthcare Co-Invest VI L.P., Fairmount Healthcare Co-Invest V L.P., Fairmount Healthcare Co-Invest IV L.P., Fairmount Healthcare Co-Invest III L.P., Fairmount Healthcare Co-Invest II L.P., Fairmount Healthcare Co-Invest L.P..

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Peter Harwin by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 20 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Peter Harwin is listed on: none on file. No website or social profile named in Galecto, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #52,816 of 374,652 in line (1,386 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Boston, MA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗Massachusetts MassCourts ↗Pennsylvania UJS portal case search ↗Colorado state courts — find the court ↗Texas re:SearchTX court records ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

Massachusetts Secretary of State business search ↗Pennsylvania Secretary of State business search ↗Colorado Secretary of State business search ↗Texas Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Peter Harwin appears on a new Form D, or when a court case or SEC action is matched to them. See plans →